Explore

Trendline Trendline
CADET-Hub: New Open-Source Platform Revolutionizes Bioprocess Modeling for Vaccine Manufacturers

CADET-Hub: New Open-Source Platform Revolutionizes Bioprocess Modeling for Vaccine Manufacturers

CADET-Hub: New Open-Source Platform Revolutionizes Bioprocess Modeling for Vaccine Manufacturers
Trendline Trendline
Inno4Vac Consortium Develops CADET-Hub for Bioprocess Optimization

Inno4Vac Consortium Develops CADET-Hub for Bioprocess Optimization

Inno4Vac Consortium Develops CADET-Hub for Bioprocess Optimization
Trendline Trendline
Nu-Tek BioSciences Advances Animal-Free Raw Materials at BIO 2026

Nu-Tek BioSciences Advances Animal-Free Raw Materials at BIO 2026

Nu-Tek BioSciences Advances Animal-Free Raw Materials at BIO 2026
Trendline Trendline
Nu-Tek BioSciences Leads Animal-Free Raw Materials Revolution at BIO 2026

Nu-Tek BioSciences Leads Animal-Free Raw Materials Revolution at BIO 2026

Nu-Tek BioSciences Leads Animal-Free Raw Materials Revolution at BIO 2026
Trendline Trendline
Eli Lilly Acquires Three Biotech Firms for $3.8 Billion to Boost Vaccine Development

Eli Lilly Acquires Three Biotech Firms for $3.8 Billion to Boost Vaccine Development

Eli Lilly Acquires Three Biotech Firms for $3.8 Billion to Boost Vaccine Development
Trendline Trendline
WuXi Biologics Expands Global Manufacturing with New Drug Product Facility

WuXi Biologics Expands Global Manufacturing with New Drug Product Facility

WuXi Biologics Expands Global Manufacturing with New Drug Product Facility
Trendline Trendline
Eli Lilly Expands Vaccine Portfolio Amid Moderna's Stock Surge

Eli Lilly Expands Vaccine Portfolio Amid Moderna's Stock Surge

Eli Lilly Expands Vaccine Portfolio Amid Moderna's Stock Surge
Trendline Trendline
Eli Lilly Reenters Infectious Disease Market with $3.8 Billion Acquisitions

Eli Lilly Reenters Infectious Disease Market with $3.8 Billion Acquisitions

Eli Lilly Reenters Infectious Disease Market with $3.8 Billion Acquisitions
Trendline Trendline
Nu-Tek BioSciences Advances Animal-Free Raw Materials at BIO 2026, Supporting Biotech Innovation

Nu-Tek BioSciences Advances Animal-Free Raw Materials at BIO 2026, Supporting Biotech Innovation

Nu-Tek BioSciences Advances Animal-Free Raw Materials at BIO 2026, Supporting Biotech Innovation
Trendline Trendline
Eli Lilly Acquires Three Companies to Enhance Infectious Disease Portfolio

Eli Lilly Acquires Three Companies to Enhance Infectious Disease Portfolio

Eli Lilly Acquires Three Companies to Enhance Infectious Disease Portfolio
Trendline Trendline
Omios Biologics Launches ODE Platform to Enhance Therapeutic Discovery

Omios Biologics Launches ODE Platform to Enhance Therapeutic Discovery

Omios Biologics Launches ODE Platform to Enhance Therapeutic Discovery
Trendline Trendline
Eli Lilly Expands Vaccine Portfolio Amid Moderna's Stock Surge Due to Hantavirus Concerns

Eli Lilly Expands Vaccine Portfolio Amid Moderna's Stock Surge Due to Hantavirus Concerns

Eli Lilly Expands Vaccine Portfolio Amid Moderna's Stock Surge Due to Hantavirus Concerns